Select Publications
Journal articles
2001, 'Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease', American Journal of Pathology, 158, pp. 2165 - 2175, http://dx.doi.org/10.1016/S0002-9440(10)64688-3
,2001, 'Executive functions in very old individuals and MRI white matter lesions: Do they matter? Evidence from the Sydney Older Persons Study', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202876001407&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Clinical diagnosis and disability among community dwellers aged 75 and over: The Sydney older persons study.', Australasian Journal on Ageing, 20, pp. 67 - 72
,2001, 'Progressive supranuclear palsy, frontotemporal dementia with parkinsonism linked to chromosome 17 and familial tauopathies.', Brain, 124, pp. 1668 - 1670
,2001, 'Variable phenotypes of Alzheimer`s disease with spastic paraparesis', Annals of Neurology, pp. 125 - 129
,2000, 'Clinical issues - Anaemia and dementia in community-dwelling Australian elderly', AUSTRALASIAN JOURNAL ON AGEING, 19, pp. 25 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086449500094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Anti-inflammatory drugs protect against Alzheimer's disease at low doses', Archives of Neurology, pp. 1586 - 1591
,2000, 'Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Expansion of the disease phenotype caused by tau gene mutations', Brain, 123, pp. 880 - 893
,2000, 'Tau gene mutations are pleiotropic: Identification of two novel mutations in the tau gene', Neurobiology of Aging, 21, pp. 36 - 36, http://dx.doi.org/10.1016/s0197-4580(00)82837-7
,2000, 'Variable presentation of Alzheimer's disease and/or spastic paraparesis phenotypes in pedigrees with a novel PS-1 exon 9 gene deletion or exon 9 splice acceptor mutations', Neurobiology of Aging, 21, pp. 25 - 25, http://dx.doi.org/10.1016/s0197-4580(00)82789-x
,1999, 'Evidence for association of anaemia with vascular dementia', NeuroReport, 10, pp. 2377 - 2381, http://dx.doi.org/10.1097/00001756-199908020-00029
,1999, 'The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease', NeuroReport, 10, pp. 879 - 882, http://dx.doi.org/10.1097/00001756-199903170-00038
,1999, 'Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer`s disease', Alzheimers Reports, 2, pp. 219 - 223
,1999, 'Neuropathology of three clinical cases prospectively diagnosed with diffuse Lewy body disease', Journal of Clinical Neuroscience, pp. 149 - 154
,1998, 'No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia', Neuroscience Letters, 246, pp. 178 - 180, http://dx.doi.org/10.1016/S0304-3940(98)00248-1
,1998, 'Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.', Neuroreport, pp. 3335 - 3339
,1997, 'Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease', Neuroscience, 78, pp. 641 - 652, http://dx.doi.org/10.1016/S0306-4522(96)00569-6
,1997, 'Further evidence for an association between a mutation in the APP gene and Lewy body formation', Neuroscience Letters, pp. 49 - 52
,1997, 'Nucleus basalis cell loss is related to regional volumetric brain changes in Alzheimer's disease', Neuroscience, pp. 641 - 652
,1997, 'Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer`s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype', Neuroreport, pp. 1537 - 1542
,1996, 'Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample', Australian and New Zealand Journal of Medicine, 26, pp. 658 - 661, http://dx.doi.org/10.1111/j.1445-5994.1996.tb02936.x
,1996, 'Diffuse Lewy body disease: Clinical features in nine cases without co-existent Alzheimer's disease', Journal of Neurology Neurosurgery and Psychiatry, pp. 532 - 538
,1996, 'Quantification of cortical atrophy in a case of progressive fluent asphsia', Brain, 119, pp. 181 - 190
,1996, 'Topography of brain atrophy during normal aging and Alzheimer's disease', Neurobiology of Aging, 17, pp. 513 - 521
,1995, 'A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease', Neuroscience Letters, 199, pp. 183 - 186, http://dx.doi.org/10.1016/0304-3940(95)12046-7
,1995, 'ApoE genotypes in australia: Roles in early and late onset alzheimer’s disease and down’s syndrome', NeuroReport, 6, pp. 1513 - 1516, http://dx.doi.org/10.1097/00001756-199507310-00012
,1994, 'Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: Double blind trial', BMJ, 308, pp. 879, http://dx.doi.org/10.1136/bmj.308.6933.879
,1993, 'Plasma amyloid precursor protein is decreased in alzheimer’s disease', NeuroReport, 4, pp. 757 - 759, http://dx.doi.org/10.1097/00001756-199306000-00040
,1992, 'Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation', Acta Neuropathologica, 84, pp. 638 - 650, http://dx.doi.org/10.1007/BF00227741
,